Literature DB >> 24842055

Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.

Domokos Gerö1, Petra Szoleczky1, Athanasia Chatzianastasiou2, Andreas Papapetropoulos2, Csaba Szabo1.   

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) activation is a hallmark of oxidative stress-induced cellular injury that can lead to energetic failure and necrotic cell death via depleting the cellular nicotinamide adenine dinucleotide (NAD(+)) and ATP pools. Pharmacological PARP-1 inhibition or genetic PARP-1 deficiency exert protective effects in multiple models of cardiomyocyte injury. However, the connection between nuclear PARP-1 activation and depletion of the cytoplasmic and mitochondrial energy pools is poorly understood. By using cultured rat cardiomyocytes, here we report that ring finger protein 146 (RNF146), a cytoplasmic E3-ubiquitin ligase, acts as a direct interactor of PARP-1. Overexpression of RNF146 exerts protection against oxidant-induced cell death, whereas PARP-1-mediated cellular injury is augmented after RNF146 silencing. RNF146 translocates to the nucleus upon PARP-1 activation, triggering the exit of PARP-1 from the nucleus, followed by rapid degradation of both proteins. PARP-1 and RNF146 degradation occurs in the early phase of myocardial ischemia-reperfusion injury; it precedes the induction of heat shock protein expression. Taken together, PARP-1 release from the nucleus and its rapid degradation represent newly identified steps of the necrotic cell death program induced by oxidative stress. These steps are controlled by the ubiquitin-proteasome pathway protein RNF146. The current results shed new light on the mechanism of necrotic cell death. RNF146 may represent a distinct target for experimental therapeutic intervention of oxidant-mediated cardiac injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24842055      PMCID: PMC4153837          DOI: 10.2119/molmed.2014.00102

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  52 in total

Review 1.  Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.

Authors:  Amos A Fatokun; Valina L Dawson; Ted M Dawson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury.

Authors:  Z Yang; B Zingarelli; C Szabó
Journal:  Shock       Date:  2000-01       Impact factor: 3.454

3.  Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury.

Authors:  Z Yang; B Zingarelli; C Szabó
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

4.  Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes.

Authors:  Emese Tóth-Zsámboki; Eszter Horváth; Katarina Vargova; Eszter Pankotai; Kanneganti Murthy; Zsuzsanna Zsengellér; Tamás Bárány; Tamás Pék; Katalin Fekete; Róbert Gábor Kiss; István Préda; Zsombor Lacza; Domokos Gerö; Csaba Szabó
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

5.  Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

Authors:  H C Ha; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.

Authors:  Prakash Jagtap; Francisco Garcia Soriano; László Virág; Lucas Liaudet; Jon Mabley; Eva Szabó; György Haskó; Anita Marton; Clara Batista Lorigados; Ferenc Gallyas; Balázs Sümegi; Dale G Hoyt; Erkan Baloglu; John VanDuzer; Andrew L Salzman; Garry J Southan; Csaba Szabó
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

7.  Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction.

Authors:  Tamás Radovits; Leila Seres; Domokos Gero; Irina Berger; Csaba Szabó; Matthias Karck; Gábor Szabó
Journal:  Exp Gerontol       Date:  2007-02-20       Impact factor: 4.032

8.  Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury.

Authors:  Yichen Lai; Yaming Chen; Simon C Watkins; Paula D Nathaniel; Fengli Guo; Patrick M Kochanek; Larry W Jenkins; Csaba Szabó; Robert S B Clark
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

9.  Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.

Authors:  Domokos Gerö; Katalin Módis; Nóra Nagy; Petra Szoleczky; Zoltán Dóri Tóth; György Dormán; Csaba Szabó
Journal:  Int J Mol Med       Date:  2007-11       Impact factor: 4.101

10.  Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.

Authors:  Tamás Radovits; Li-ni Lin; Julia Zotkina; Domokos Gero; Csaba Szabó; Matthias Karck; Gábor Szabó
Journal:  Eur J Pharmacol       Date:  2007-03-12       Impact factor: 4.432

View more
  10 in total

1.  Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.

Authors:  Sevil Korkmaz-Icöz; Bartosz Szczesny; Michela Marcatti; Shiliang Li; Mihály Ruppert; Felix Lasitschka; Sivakkanan Loganathan; Csaba Szabó; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-10-02       Impact factor: 8.739

Review 2.  The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival.

Authors:  T Jubin; A Kadam; M Jariwala; S Bhatt; S Sutariya; A R Gani; S Gautam; R Begum
Journal:  Cell Prolif       Date:  2016-06-22       Impact factor: 6.831

3.  Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes.

Authors:  Domokos Gero; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2015-10-14       Impact factor: 8.739

4.  Olesoxime Inhibits Cardioplegia-Induced Ischemia/Reperfusion Injury. A Study in Langendorff-Perfused Rabbit Hearts.

Authors:  Aida Salameh; Maren Keller; Ingo Dähnert; Stefan Dhein
Journal:  Front Physiol       Date:  2017-05-19       Impact factor: 4.566

5.  RNF146 Inhibits Excessive Autophagy by Modulating the Wnt-β-Catenin Pathway in Glutamate Excitotoxicity Injury.

Authors:  Yuefan Yang; Peng Luo; Haoxiang Xu; Shuhui Dai; Wei Rao; Cheng Peng; Wenke Ma; Jiu Wang; Hongyu Xu; Lei Zhang; Sai Zhang; Zhou Fei
Journal:  Front Cell Neurosci       Date:  2017-03-06       Impact factor: 5.505

6.  HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.

Authors:  Laura Lucarini; Mariaconcetta Durante; Cecilia Lanzi; Alessandro Pini; Giulia Boccalini; Laura Calosi; Flavio Moroni; Emanuela Masini; Guido Mannaioni
Journal:  J Cell Mol Med       Date:  2016-10-04       Impact factor: 5.310

7.  Effect of 3-Aminobenzamide on the Ultrastructure of Astrocytes and Microvessels After Focal Cerebral Ischemia in Rats.

Authors:  Jinqiao Wang; Chunyan Ma; Jing Zhu; Gaofeng Rao; Hongjuan Li
Journal:  Dose Response       Date:  2020-01-22       Impact factor: 2.658

8.  Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress.

Authors:  Gábor Oláh; Bartosz Szczesny; Attila Brunyánszki; Isabel A López-García; Domokos Gerö; Zsolt Radák; Csaba Szabo
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

9.  Glucocorticoids Suppress Mitochondrial Oxidant Production via Upregulation of Uncoupling Protein 2 in Hyperglycemic Endothelial Cells.

Authors:  Domokos Gerö; Csaba Szabo
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

10.  Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts.

Authors:  Aida Salameh; Roxana Schuster; Ingo Dähnert; Johannes Seeger; Stefan Dhein
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.